Article Text

Download PDFPDF

Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
  1. Veronika Kremer1,
  2. Maarten A. Ligtenberg2,
  3. Rosa Zendehdel1,
  4. Christina Seitz3,
  5. Annet Duivenvoorden1,
  6. Erik Wennerberg4,
  7. Eugenia Colón5,6,
  8. Ann-Helén Scherman-Plogell7 and
  9. Andreas Lundqvist1,8,i
  1. Aff1 0000 0004 1937 0626grid.4714.6Department of Oncology-PathologyKarolinska Institutet Stockholm Sweden
  2. Aff2 grid.430814.aDepartment of Molecular OncologyThe Netherlands Cancer Institute Amsterdam Netherlands
  3. Aff3 0000 0004 1937 0626grid.4714.6Department of Medicine SolnaKarolinska Institutet Stockholm Sweden
  4. Aff4 000000041936877Xgrid.5386.8Department of Radiation OncologyWeill Cornell Medicine New York NY USA
  5. Aff5 0000 0000 8986 2221grid.416648.9Department of Oncology-PathologyStockholm South General Hospital Stockholm Sweden
  6. Aff6 0000 0004 1937 0626grid.4714.6Department of Woman and Child HealthKarolinska Institutet Stockholm Sweden
  7. Aff7 0000 0000 8986 2221grid.416648.9Department of UrologyStockholm South General Hospital Stockholm Sweden
  8. Aff8 0000 0001 2168 8324grid.261241.2Cell Therapy InstituteNova Southeastern University Fort Lauderdale FL USA
  1. i Andreas.lundqvist{at}ki.se
  • The online version of the original chapter can be found at 10.1186/s40425-017-0275-9.

Statistics from Altmetric.com

Unfortunately, after publication of this article [1], it was noticed that the name of Maarten A. Ligtenberg was displayed incorrectly as Maarten Ligtenberg. The correct author list can be seen above and the original article has been updated to reflect this.

Reference

  1. 1.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.